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Synaptotagmin-like protein 4-a (Slp4-a)/granuphilin-a is specifically localized on dense-core vesicles in certain neuroen-
docrine cells and negatively controls dense-core vesicle exocytosis through specific interaction with Rab27A. However, the
precise molecular mechanism of its inhibitory effect on exocytosis has never been elucidated and is still a matter of
controversy. Here we show by deletion and chimeric analyses that the linker domain of Slp4-a interacts with the
Munc18-1syntaxin-1a complex by directly binding to Munc18-1 and that this interaction promotes docking of dense-core
vesicles to the plasma membrane in PC12 cells. Despite increasing the number of plasma membrane docked vesicles,
expression of Slp4-a strongly inhibited high-KCl–induced dense-core vesicle exocytosis. The inhibitory effect by Slp4-a
is absolutely dependent on the linker domain of Slp4-a, because substitution of the linker domain of Slp4-a by that of
Slp5 (the closest isoform of Slp4-a that cannot bind the Munc18-1syntaxin-1a complex) completely abrogated the
inhibitory effect. Our findings reveal a novel docking machinery for dense-core vesicle exocytosis: Slp4-a simultaneously
interacts with Rab27A and Munc18-1 on the dense-core vesicle and with syntaxin-1a in the plasma membrane.
INTRODUCTION
Peptide hormones are stored in large dense-core vesicles in
neuroendocrine cells and are released by exocytosis. Soluble
N-ethylmaleimide-sensitive factor attachment protein recep-
tors (SNAREs; Rothman, 1994; Jahn and Südhof, 1999; Rizo
and Südhof, 2002) and Rab GTPases (Segev, 2001; Zerial and
McBride, 2001) are thought to be required for biogenesis and
trafficking of hormone-containing vesicles. The dense-core
vesicle trafficking to the plasma membrane consists of at
least three distinct steps: the transport of dense-core vesicles
to the plasma membrane (recruitment), their initial interac-
tion with the plasma membrane (docking or tethering), and
their subsequent fusion with the plasma membrane (fusion).
Although SNARE proteins are thought to regulate the final
fusion step(s) in neuroendocrine cells (An and Almers,
2004), the molecular machinery involved in the initial dock-
ing or tethering step(s) remains largely unknown.
The synaptotagmin-like protein (Slp) family is a group of pu-
tative membrane trafficking proteins (Fukuda and Mikoshiba,
2001; Fukuda et al., 2001) that are characterized by the pres-
ence of an N-terminal Slp homology domain (SHD), which
functions as a Rab27-binding domain (Kuroda et al., 2002a;
Strom et al., 2002; Yi et al., 2002), and C-terminal tandem C2
domains (known as the C2A domain and C2B domain),
putative Ca2-binding motifs (Fukuda, 2002). To date, five
members of the Slp family (Slp1/Jfc1, Slp2-a, Slp3-a, Slp4-
a/granuphilin-a, and Slp5) have been identified in the
mouse and human (Wang et al., 1999; Fukuda et al., 2001;
McAdara Berkowitz et al., 2001; Kuroda et al., 2002b). It has
recently been proposed that members of the Slp family and
of the Slp homologue lacking C2 domains (Slac2) family
function as effector molecules for small GTPase Rab27A/B
and regulate Rab27A/B-dependent secretion events (re-
viewed in Cheviet et al., 2004; Fukuda, 2005). For example,
Slp4-a/granuphilin-a is coexpressed with Rab27A in certain
neuroendocrine cells, and both proteins are concentrated on
dense-core vesicles (Wang et al., 1999; Coppola et al., 2002;
Fukuda et al., 2002; Yi et al., 2002; Waselle et al., 2003; Desnos
et al., 2003). Expression of Rab27A in pancreatic -cell lines
enhances depolarization-induced insulin secretion (Yi et al.,
2002), whereas expression of Slp4-a inhibits exocytosis in
pancreatic -cell lines, AtT20 cells, and PC12 cells (Fukuda et
al., 2002; Coppola et al., 2002; Torii et al., 2002; Zhao et al.,
2002), whereas other members of the Slp family are not
inhibitory and instead promote dense-core vesicle exocyto-
sis in PC12 cells (Fukuda et al., 2002; Fukuda, 2003). How-
ever, the precise mechanism of the inhibitory effect by Slp4-a
has never been elucidated and is still a matter of controversy
(Coppola et al., 2002; Fukuda, 2003; Torii et al., 2004).
In this study we investigated the function of Slp4-a in the
motion of a single dense-core vesicle during exocytosis by total
internal reflection fluorescence (TIRF; also called evanescent
This article was published online ahead of print in MBC in Press
(http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E05–11–1047)
on February 15, 2006.
□D The online version of this article contains supplemental material
at MBC Online (http://www.molbiolcell.org).
Address correspondence to: Mitsunori Fukuda (mnfukuda@brain.
riken.go.jp).
Abbreviations used: GFP, green fluorescent protein; HA, hemaggluti-
nin; HRP, horseradish peroxidase; mRFP, monomeric red fluorescent
protein; NPY, neuropeptide Y; SHD, Slp homology domain; siRNA,
small interfering RNA; Slac2, Slp homologue lacking C2 domains; Slp,
synaptotagmin-like protein; SNAP-25, synaptosome-associated protein
of 25 kDa; SNARE, soluble N-ethylmaleimide–sensitive factor attach-
ment protein receptor; VAMP-2; vesicle-associated membrane pro-
tein-2; Venus, pH-insensitive yellow fluorescent protein; TIRF, total
internal reflection fluorescence.
© 2006 by The American Society for Cell Biology 2101
wave or evanescence) microscopy (Axelrod, 1981) with vesicle-
targeted fluorescent proteins (Tsuboi et al., 2000, 2003, 2004,
2005; Tsuboi and Rutter, 2003; Tsuboi and Fukuda, 2005). Ex-
pression of Slp4-a in PC12 cells induced a significant increase
in the number of vesicles docked to the plasma membrane and
a significant decrease in the number of single exocytotic events,
without affecting release kinetics of peptide hormones. By con-
trast, RNA interference–mediated knockdown of endogenous
Slp4-a resulted in a decrease in the number of docked vesicles
and increase in the number of exocytotic events. Analysis using
deletion mutants and chimeric Slp4-a proteins further indi-
cated that the inhibitory effect of Slp4-a on exocytosis is depen-
dent on its ability to bind Munc18-1, a SNARE-associated pro-
tein that binds the closed conformation of syntaxin-1a (Rizo
and Südhof, 2002; Toonen and Verhage, 2003), and Rab27A.
Based on these findings, we propose that Slp4-a is the funda-
mental machinery for anchoring dense-core vesicles to the
plasma membrane through specific interaction with the
Munc18-1syntaxin-1a complex in neuroendocrine cells.
MATERIALS AND METHODS
Plasmid Construction
The following pairs of nucleotides with a 19-base target site (in bold) and a 9-base
loop (underlined) were used to generate small interfering RNA (siRNA) expres-
sion plasmids against rat and mouse Slp4-a mRNA: Slp4-a siRNA() primer
(5-AACTCCTGTGATGAAGAAGTTCAAGAGACTTCTTCATCACAGGA-
GTTTTTTTT-3) and Slp4-a siRNA(-) primer (5-AATTAAAAAAAACTC-
CTGTGATGAAGAAGTCTCTTGAACTTCTTCATCACAGGAGTTGGCC-
3). The pairs of nucleotides were mixed, denatured at 94°C for 2 min, annealed
at 72°C for 1 min, gradually cooled to 4°C for 2 h, and then subcloned into the
ApaI and EcoRI sites of the pSilencer 1.0-U6 vector (Ambion, Austin, TX), which
expresses short hairpin RNA under the control of the mouse U6 promoter. The
plasmid obtained was referred to as pSilencer-Slp4-a. The knockdown efficiency
of pSilencer-Slp4-a was evaluated in COS7 cells or PC12 cells as described
previously (Fukuda, 2004; Kuroda and Fukuda, 2004).
The Slp1, Slp2-a, Slp3-a, Slp4-a, Slp5, Slp3-a-C2B, Slp3-a-C2AB, Slp4-a-
C2B, Slp4-a-C2AB, Slp5-C2B, and Slp5-C2AB cDNA fragments (Kuroda
et al., 2002a, 2002b; Fukuda et al., 2005) were subcloned into the BamHI/NotI
site of the pmRFP-C1-gk vector (Tsuboi and Fukuda, 2005) modified from
pmRFP-C1 (BD Clontech, Palo Alto, CA) by introducing a short Gly linker just
downstream of mRFP (monomeric red fluorescent protein; Campbell et al.,
2002). Plasmid encoding neuropeptide Y-tagged pH-insensitive yellow fluo-
rescent protein, NPY-Venus (pVenus-N1-NPY), was generously provided by
Dr. Atsushi Miyawaki (Nagai et al., 2002). Other expression constructs were
prepared as described elsewhere (see Fukuda et al., 2005 and references
therein).
Construction of Chimeric Plasmid between Slp4 and Slp5
The N-terminal SHD-swapping chimeras (Slp455 and Slp544; see Figure 5A)
and the C2A-domain-swapping chimeras (Slp445 and Slp554) were prepared
by two-step or conventional PCR techniques essentially as described previ-
ously (Fukuda et al., 1995). For example, the Slp445 (i.e., Slp4-SHDSlp4-
linkerSlp5-C2A) cDNA was constructed by linking two separate PCR prod-
ucts: the Slp4-SHDSlp4-linker fragment, amplified with the BOS-5 primer
(5-GTTCATTCTCAAGCCTC-3)andSlp4-linker-3primer(5-AGATCTCAC-
CGGTGACTTTCACGTTCCCAAAATCACCAGCTTCGCT-3; BglII site, un-
derlined) by using pEF-T7-Slp4-b as the template, and the Slp5-C2A fragment,
amplified with the Slp5-C2A-5 primer (5-AGATCTTACTCCACATCAGCT-
AC-3; BglII site, underlined) and BOS-3 primer (5-CACGTGGGAGACCTG-
AT-3) by using pEF-T7-Slp5-C2B as the template. These PCR products were
subcloned into pGEM-T Easy vector (Promega, Madison, WI) and verified by
DNA sequencing. The Slp5-C2A fragment was cleaved with BglII/SpeI and
subcloned into the BglII/SpeI site of the pGEM-T-Slp4-SHDlinker. The
pGEM-T-Slp445 obtained was cleaved with BamHI/NotI and subcloned into
the BamHI/NotI site of the pmRFP-C1-gk vector (referred to as pmRFP-C1-
Slp445). pmRFP-C1-Slp455, pmRFP-C1-Slp554, and pmRFP-C1-Slp544 were
similarly constructed by using the above PCR techniques and the following primers:
5-CCCGGGACTTCTCTTCTGGCGCAGGGACATCCT-3 (Slp4-SHD-3 primer;
SmaI site, underlined) and 5-CCCGGGTCTGAAGAAACACAAAACCAA-3
(Slp5-linker-5 primer; SmaI site, underlined); 5-CTTAAGTGAAAAGGCAAT-
CTTGCCCGTCACAGAGATGTTGCCATAGTCTCCCGTTTCACT-3 (Slp5-
linker-3 primer; AflII site, underlined) and 5-CTTAAGTTTGAGCAGAAAACA-
CAG-3 (Slp4-C2A-5 primer; AflII site, underlined); and 5-CTTAAG-
ACCTGCAGTGAATAAAAGAGAG-3 (Slp4-linker-5 primer; AflII site,
underlined). The linker domain-swapping chimeras (Slp454 and Slp545)
were then produced by substitution of the BamHI/BstXI insert of pmRFP-
C1-Slp455 for that of pmRFP-C1-Slp544 and by substitution of the BamHI/
BstXI site of pmRFP-C1-Slp544 for that of pmRFP-C1-Slp445. The sequence
of all plasmid inserts was verified by automated sequencing. The addition
of the T7 tag to the N terminus of Slp445, Slp455, Slp554, Slp544, Slp454,
and Slp545 and construction of expression vectors (pEF-T7-Slp445, pEF-
T7-Slp455, pEF-T7-Slp554, pEF-T7-Slp544, pEF-T7-Slp454, and pEF-T7-
Slp545) were performed as described previously (Mizushima and Nagata,
1990; Fukuda et al., 1994, 1999).
Immunoprecipitation and Immunoblotting
COS-7 cells were cultured in DMEM supplemented with 10% fetal bovine
serum (FBS), 100 U/ml penicillin G, and 100 g/ml streptomycin. pEF-FLAG-
syntaxin-1a, pEF-FLAG-Munc18-1, pEF-HA-Rab27A, or pEF-T7-Slp4/5 chi-
meric constructs (4 g of plasmids in total) were transfected into COS7 cells
(one confluent 10-cm dish) by using LipofectAmine Plus reagent according to
the manufacturer’s instructions. Cells were harvested 72 h after transfection
and homogenized in 1 ml of the homogenization buffer as described previ-
ously (Fukuda and Kanno, 2005). The associations between these proteins
were evaluated by immunoprecipitation as described previously (Fukuda,
2003; Fukuda and Kanno, 2005). Immunoreactive bands were visualized with
horseradish peroxidase (HRP)-conjugated anti-T7 tag antibody (1/10,000;
Novagen, Madison, WI), HRP-conjugated anti-FLAG tag antibody (M2;
1/10,000 dilution; Sigma Chemical Co., St. Louis, MO), and HRP-conjugated
anti-HA tag antibody (1/10,000; Sigma Chemical Co.), and detected by en-
hanced chemiluminescence (ECL; Amersham Biosciences, Buckinghamshire,
United Kingdom).
PC12 cells were cultured in DMEM supplemented with 10% FBS, 10% horse
serum, 100 U/ml penicillin G, and 100 g/ml streptomycin, at 37°C under 5%
CO2. pEF-T7-Slp4-b, pEF-T7-Slp454, pEF-T7-Slp5-C2B, or pEF-T7-Slp545
chimeric plasmids (4 g of plasmids in total) were transfected into PC12 cells
(2  106 cells, the day before transfection/10-cm dish) by using Lipo-
fectAmine 2000 according to the manufacturer’s instructions. Cells were
harvested 72 h after transfection and homogenized in 1 ml of a buffer con-
taining 50 mM HEPES-KOH, pH 7.2, 250 mM NaCl, 0.5 mM GTPS, 0.1 mM
phenylmethylsulfonyl fluoride, 10 M leupeptin, and 10 M pepstatin A.
After solubilization with 1% Triton X-100 at 4°C for 1 h, the supernatants (400
l) were obtained by centrifugation at 15,000 rpm for 10 min. After incubation
with anti-T7 tag antibody-conjugated agarose (wet volume 15 l; Novagen) at
4°C for 1 h, the beads were washed five times with 1 ml of 50 mM HEPES-KOH,
pH 7.2, 250 mM NaCl, 0.2% Triton X-100, and protease inhibitors and then
resuspended in SDS sample buffer. Immunoprecipitates were subjected to 10%
SDS-PAGE followed by immunoblotting with anti-syntaxin-1 antibody (1/100
dilution; Santa Cruz Biotechnology, Santa Cruz, CA), anti-Munc18-1 antibody
(1/100 dilution; BD Transduction Laboratories, Lexington, KY), and anti-Rab27A
antibody (2 g/ml; Imai et al., 2004). Immunoreactive bands were visualized
with HRP-conjugated goat anti-mouse or anti-rabbit IgG (1/10,000 dilution) and
detected by ECL. Expression of actin, SNAP-25 (synaptosome-associated protein
of 25 kDa), and VAMP-2 (vesicle-associated membrane protein-2) in PC12 cells
was investigated by immunoblotting with commercially available antibodies as
described previously (Fukuda, 2004).
Confocal Imaging
For microscopic analysis, PC12 cells were fixed with 4% paraformaldehyde
(Wako Pure Chemicals, Osaka, Japan) for 20 min. For immunostaining, cells
were permeabilized with 0.3% Triton X-100 for 2 min and blocked with the
blocking buffer (1% BSA and 0.1% Triton X-100 in PBS) for 1 h. The cells were
then immunostained with the primary antibodies, followed by Alexa-Fluor
488–labeled or 568–labeled secondary IgG (1/5000 dilution; Molecular
Probes, Eugene, OR). The cells were examined for fluorescence with a con-
focal laser-scanning microscope (Fluoview 500, Olympus, Tokyo, Japan), and
the images were processed with MetaMorph software (version 6.3, Universal
Imaging, Downingtown, PA).
TIRF Microscopy
PC12 cells were cultured as described above. For TIRF imaging, PC12 cells
were plated onto poly-l-lysine–coated coverslips and then cotransfected with
1 g of pVenus-N1-NPY, and either 3 g of pmRFP-C1 (a vector control),
pmRFP-C1-Slp15, or pmRFP-C1–4/5-swapping constructs by using Lipo-
fectAmine 2000 reagent according to the manufacturer’s instructions. To
knockdown endogenous Slp4-a protein expression, we cotransfected with 3
g of pSilencer-Slp4-a vector and 1 g of NPY-Venus vector into PC12 cells.
Expression of each mRFP fusion protein and NPY-Venus was confirmed by
immunoblotting with anti-DsRed antibody (1/250 dilution; MBL, Nagoya,
Japan) and anti-GFP (green fluorescent protein) antibody (1/250 dilution;
MBL), respectively. Expression of mRFP-Slp and endogenous Slp proteins in
PC12 cells was also investigated by immunoblotting with isoform-specific
antibodies as described previously (Imai et al., 2004; Supplementary Figure 1).
Based on the relative signals of exogenous mRFP-Slp4-a and endogenous
Slp4-a (mRFP-Slp4-a/endogenous Slp4-a, 9.1:1) and the maximum transfec-
tion efficiency (50%), the expression levels of transiently expressed Slp4-a
(or presumably other Slps and their mutants) were estimated to be 18 times
higher than those of endogenous Slp4-a (Supplementary Figure 1D). The
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imaging was performed at 37°C in a modified Ringer buffer (RB: 130 mM
NaCl, 3 mM KCl, 5 mM CaCl2, 1.5 mM MgCl2, 10 mM glucose, and 10 mM
HEPES, pH 7.4). Stimulation with high-KCl was achieved by perfusion with
70 mM KCl containing RB (NaCl was reduced to maintain the osmolarity).
Exocytosis of NPY-Venus at the single vesicle level was monitored with a
TIRF microscope essentially as described previously (Tsuboi et al., 2000, 2003,
2004, 2005; Tsuboi and Rutter, 2003; Tsuboi and Fukuda, 2005). Images were
acquired every 200 ms, or otherwise as indicated. To analyze the TIRF
imaging data, single exocytotic events were selected manually (see below for
details), and the average fluorescence intensity of individual vesicle in a 0.7 
0.7-m square placed over the vesicle center was calculated. To distinguish
between fusion events and vesicle movement (i.e., vesicles pause at the
plasma membrane and then move back inside the cell without fusing), we
focused on fluorescence changes just before the disappearance of fluorescent
signals. When there was a fusion event, a rapid transient increase in fluores-
cence intensity (to a peak intensity 1.5 times greater than the original fluo-
rescence intensity within 1 s) was observed, whereas when vesicles moved,
the fluorescence intensity gradually decreased to the background level (see
closed squares and open circles, respectively, in Figure 3B). The number of
fusion events during a 5-min period was counted manually based on the
above criteria. Data are reported as means  SE of at least five individual
experiments. Means were compared by one-way ANOVA with GraphPad
Prism software (GraphPad Software, San Diego, CA).
RESULTS
Slp Family Proteins Are Associated with Dense-Core
Vesicles in PC12 Cells
To determine whether Slp family members are specifically
targeted to dense-core vesicles, we simultaneously labeled the
dense-core vesicle cargo and Slp family proteins in PC12 cells
by coexpressing pH-insensitive yellow fluorescent protein mu-
tant-tagged neuropeptide Y (NPY-Venus), which are efficiently
targeted to the dense-core vesicles (Nagai et al., 2002), and
monomeric red fluorescent protein (mRFP)-tagged Slp15.
Confocal microscopy revealed that most NPY-Venus–positive
Figure 1. Colocalization of Slp proteins with secretory
vesicles in PC12 cells. NPY-Venus (A, D, G, J, and M) and
mRFP-Slp1 (B), mRFP-Slp2-a (E), mRFP-Slp3-a (H), mRFP-
Slp4-a (K), or mRFP-Slp5 (N) were coexpressed in PC12
cells, and images of the fixed cells were obtained by con-
focal microscopy. Note that all five mRFP-Slps colocalized
well with NPY-Venus, a dense-core vesicle marker (C, F, I,
L, and O). Scale bar, 5 m.
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vesicles colocalized with mRFP-Slp1–positive vesicles (Figure
1, A–C; 83.5  4.6%, 7 cells), indicating efficient targeting of
mRFP-Slp1 to dense-core vesicles, where Rab27A is enriched.
Similarly, most mRFP-Slp2-a- (Figure 1, D–F; 73.4  5.6%, 6
cells), mRFP-Slp3-a- (Figure 1, G–I; 91.1  6.6%, 5 cells), mRFP-
Slp4-a- (Figure 1, J–L; 87.4  7.3%, 6 cells), and mRFP-Slp5-
labeled (Figure 1, M–O; 73.2  3.2%, 5 cells) structures colocal-
ized with NPY-Venus.
Slp4-a, But Not Other Slps, Increased the Number of
Vesicles Docked to the Plasma Membrane and Inhibited
the Number of Exocytotic Events
The efficient targeting of mRFP-Slp proteins to dense-core ves-
icles that contain NPY-Venus has enabled us to further analyze
the impact of Slp proteins on the dynamics of single exocytotic
events within 100 nm beneath the plasma membrane in PC12
cells by TIRF microscopy (Tsuboi and Fukuda, 2005). Counting
the number of plasma membrane-docked vesicles in resting
PC12 cells by TIRF microscopy revealed that expression of
mRFP-Slp4-a significantly increased (to 155.9%) the number of
plasma membrane-docked vesicles (Figure 2, A, bottom mid-
dle panel, and C), whereas expression of other Slps had no
effect at all. The effect by Slp4-a should not be attributable to the
change in the total number of vesicles or the excess amount of
mRFP-Slp4-a protein, because the expression levels of NPY-
Venus in the control and mRFP-Slp–expressing cells were al-
most similar (Figure 2B, middle panel) and the same expres-
sion levels of mRFP-Slp15 were observed (Figure 2B, top
panel). Next we counted the total number of NPY-Venus re-
lease events (i.e., dense-core vesicle exocytosis) by cells ex-
pressing NPY-Venus together with each mRFP-Slp member
during high-KCl (70 mM) stimulation. Because the number of
plasma membrane–docked vesicles before stimulation and
number of NPY-Venus release events differed between the
transfected cells, we measured the number of NPY-Venus re-
lease events (R) during the 5-min stimulation period and the
number of plasma membrane-docked vesicles (D) before stim-
ulation and then calculated the ratio between R and D (R/D
expressed as a percent; i.e., normalized NPY-Venus release
events). Despite increasing the number of vesicles docked to
the plasma membrane, the number of NPY-Venus release
events in the mRFP-Slp4-a–expressing cells was reduced, and
the percent R/D value was thus reduced to 28.7% in compar-
ison with the control. By contrast, expression of mRFP-Slp3-a
and mRFP-Slp5 significantly increased the percent R/D values
to 173.4 and 180.5%, respectively, and mRFP-Slp1 and mRFP-
Slp2-a were again neutral in terms of normalized NPY-Venus
release events (Figure 2D), consistent with the previous bio-
chemical analyses (Fukuda et al., 2002; Fukuda, 2003; Torii et al.,
2002).
Effect of Expression of Slp3-a, Slp4-a, or Slp5 on the
Kinetics of Vesicle Fusion
To further determine whether the expression of mRFP-Slp3-a,
-Slp4-a, or -Slp5 modulates the kinetics of vesicle exocytosis, the
dynamics of single vesicle fusion events in a single NPY-Venus–
expressing vesicle near the plasma membrane was analyzed by
TIRF microscopy. High-KCl stimulation of Ca2 influx caused
Figure 2. Effect of expression of Slp15 on
the number of vesicles docked to the plasma
membrane of PC12 cells. (A) Typical TIRF im-
ages of plasma membrane-docked NPY-Venus
vesicles observed before high-KCl stimulation
in control (control), mRFP-Slp1–expressing
(Slp1), mRFP-Slp2-a–expressing (Slp2-a), mRFP-
Slp3-a–expressing (Slp3-a), mRFP-Slp4-a–ex-
pressing (Slp4-a), and mRFP-Slp5–expressing
cells (Slp5). Scale bar, 5 m. (B) Expression of
mRFP-Slp15, NPY-Venus, and actin in PC12
cells was analyzed by 10% SDS-PAGE followed
by immunoblotting with anti-DsRed antibody
(1/250 dilution), anti-GFP antibody (1/250 di-
lution), and anti-actin (1/300 dilution) anti-
body, respectively. The positions of the molec-
ular mass markers (103) are shown on the
left. (C) The density of docked vesicles was
determined by counting the vesicles in each
image (n  6 cells in each). (D) The percent of
the number of NPY-Venus release events (R)
during the 5-min stimulation to the number of
plasma membrane-docked vesicles (D) before
stimulation in mRFP-Slp–expressing cells ob-
tained by TIRF microscopy (n  6 cells in each).
Data are shown as mean values  SE. *,*** p 	
0.05 and 0.001, respectively, in comparison with
the control. Note that expression of mRFP-
Slp4-a significantly increased the number of
plasma membrane–docked vesicles (C) and de-
creased the percent R/D values (D).
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NPY-Venus–containing spots to suddenly brighten and spread
(Figure 3, A, control (fusion) panels, and B, closed squares), con-
sistent with release of the fluorescent peptides (Lang et al., 1997;
Tsuboi et al., 2003, 2004, 2005; Tsuboi and Rutter, 2003; Tsuboi and
Fukuda, 2005). By contrast, no diffuse cloud of NPY-Venus fluo-
rescence was observed in nonsecretory events (see Figure 3, A,
control (movement) panels, and B, open circles). Although exocy-
totic events were detected much less frequently in the mRFP-Slp4-
a–expressing cells than in the control cells, or mRFP-Slp3-a- or
mRFP-Slp5–expressing cells, the kinetics of individual NPY-
Venus release events was identical in all cells (Figure 3B).
To clarify whether the accumulation of docked vesicles was
secondary to a decrease in the fusion probability in mRFP-Slp4-
a–expressing cells, we investigated the change in total number
of vesicles docked to the plasma membrane during high-KCl
stimulation by tracking the motion of each docked vesicle on
sequential images. In mRFP-Slp3-a- or mRFP-Slp5–expressing
cells, the number of previously docked vesicles (i.e., vesicles
that had already docked to the plasma membrane before stim-
ulation) gradually decreased as a result of fusion or vesicle
retreat (vesicles paused at the plasma membrane and then
moved back inside the cell without fusing; green lines in Slp3-a
and Slp5 panels of Figure 3C), whereas the number of newly
recruited docked vesicles rapidly and progressively increased
after stimulation (red lines in Slp3-a and Slp5 panels of Figure
3C). As a result, the total number of docked vesicles (previ-
ously docked vesicles plus newly recruited docked vesicles)
increased to 110% of the initial number of docked vesicles
(black lines in Slp3-a and Slp5 panels of Figure 3C). By contrast,
the increase in the number of newly recruited docked vesicles
in mRFP-Slp4-a–expressing cells was almost completely pre-
vented (red line in Slp4-a panel of Figure 3C), and no change in
the number of previously docked vesicles was observed (green
line in Slp4-a panel of Figure 3C). These results indicate that
Sp4-a increases the number of “inert vesicles” docked to the
plasma membrane and decreases the number of newly re-
Figure 3. Effect of mRFP-Slp3-a, mRFP-Slp4-a,
and mRFP-Slp5 expression on the kinetics of
NPY-Venus release. (A) Typical sequential images
acquired under the TIRF microscope at 100-ms
intervals of a single NPY-Venus vesicle observed
after high-KCl (70 mM) stimulation in cells coex-
pressing a control vector (control (fusion)), mRFP-
Slp3-a (Slp3-a), mRFP-Slp4-a (Slp4-a), or mRFP-
Slp5 (Slp5). The fifth images (1.5 s) show a
diffuse cloud of NPY-Venus fluorescence, and
the sixth images (1.6 s) show disappearance of
the spot. By contrast, no diffuse cloud of NPY-
Venus fluorescence was observed in the control
(movement) vesicle (1.5 s) and then the vesicle
was gradually disappeared from the evanescent
field (1.6–3.0 s). (B) Time course of the fluores-
cence changes measured in the center of NPY-
Venus vesicles in control (fusion; f), control
(movement; ), mRFP-Slp3-a–expressing (),
mRFP-Slp4-a–expressing (), and mRFP-Slp5–
expressing (ƒ) cells. The average fluorescence
intensity before fusion was set equal to 100%
(n  15 vesicles in each). Images were acquired
every 100 ms in each condition. Note that over-
expression of Slp3-a, Slp4-a, or Slp5 had no
effect on the release kinetics of NPY-Venus by
the dense-core vesicles. By contrast, no spike
increase in the fluorescence intensity was ob-
served in the control (movement) vesicle. (C)
Time-dependent change of the number of NPY-
Venus vesicles docked to the plasma membrane
during high-KCl stimulation. The number of
previously docked vesicles that do not undergo
exocytosis (green lines) and the number of
newly recruited docked vesicles that either
dock or undergo exocytosis (red lines) during
the stimulation were determined by counting
vesicles on each image (30–50 vesicles in 25-
m2 area, n  5 cells in each) in mRFP-Slp3-a–
(left), mRFP-Slp4-a– (middle), and mRFP-Slp5–
expressing cells (right). The black line shows the
total number of docked vesicles, corresponding
to the sum of the green and red lines. Time 0
indicates the addition of the stimulation. The
number of previously docked vesicles at time 0
was taken as 100%. Data are shown as mean
values  SE.
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cruited docked vesicles during the stimulation, presumably by
occupying most of the plasma membrane docking sites. As a
result, Slp4-a dramatically decreases NPY release events (i.e.,
decease in the percent R/D value). By contrast, Slp3-a and Slp5
increase the number of newly recruited docked vesicles, but
not of previously docked vesicles, during the stimulation and
increase NPY release events (i.e., increase in the percent R/D
value).
The Linker Domain and the C2A Domain of Slp3-a,
Slp4-a, and Slp5 are Essential to Modulation of Dense-
Core Vesicle Exocytosis
In the next set of experiments we performed a systematic
deletion analysis to identify the mechanism of regulation of
dense-core vesicle exocytosis by Slp3-a, Slp4-a, or Slp5. Be-
cause we previously demonstrated that the SHD is required
for targeting to Rab27A on dense-core vesicles (Fukuda,
2003), we predicted that the linker domain or two C2 do-
mains are involved in the association with the plasma mem-
brane and produced two types of truncated mutants (i.e.,
mRFP-Slp-C2B and mRFP-Slp-C2AB; summarized in Fig-
ure 4A). We first confirmed that the expression levels of
these truncated mutants in PC12 cells were similar to those
of the full-length proteins (Figure 4C) and then performed
TIRF microscopic analysis as described above. Interestingly,
expression of mRFP-Slp-C2B had the same effects as ex-
pression of the full-length proteins did, indicating that the
C2B domain of Slp35 is not required for the control of
dense-core vesicle exocytosis (Figure 4, D and E). By con-
trast, deletion of the two C2 domains (i.e., mRFP-Slp-
C2AB) completely abrogated the function of Slp3-a, Slp4-a,
and Slp5 (Figure 4, D and E). The number of plasma mem-
brane–docked vesicles in all three C2AB mutants was sig-
nificantly decreased, even compared with the control cells
(Figure 4, B and D), and the C2AB mutants had no or little
effect on the percent R/D (i.e., normalized NPY-Venus re-
lease events; Figure 4E), indicating that the C2A domain, but
not the C2B domain, are required for the control of dense-
core vesicle exocytosis by Slp3-a, Slp4-a, and Slp5.
The Linker Domain of Slp4-a Mediates Vesicle
Docking to the Plasma Membrane
To further determine which domains (SHD, linker, C2A
domain) of Slp4-a primarily mediate the docking of dense-
Figure 4. Effect of the deletion mutants of
Slps on the number of vesicles docked to the
plasma membrane of PC12 cells. (A) Sche-
matic representation of the deletion mutants
of Slp3-a, Slp4-a, and Slp5 (i.e., C2B and
C2AB). The effects of each mutant on
plasma membrane-docked vesicles and exo-
cytosis (, , ) are indicated after its
name. (B) Typical TIRF images of plasma
membrane–docked vesicles observed before
high-KCl stimulation in control (control), mRFP-
Slp3-a– expressing (Slp3-a), mRFP-Slp3-a-







(Slp5-C2AB) cells. Scale bar, 5 m. (C) Ex-
pression of the deletion mutants of Slps and
actin in PC12 cells visualized with anti-DsRed
antibody and anti-actin antibody, respec-
tively. The positions of the molecular mass
markers (103) are shown on the left. (D)
The density of docked vesicles was deter-
mined by counting the vesicles in each image
(n  6 cells in each). (E) The effect of expres-
sion of deletion mutants of Slps on the per-
cent R/D values (n  6 cells in each). Data are
shown as mean values  SE. *,**,*** p 	 0.05,
0.01, and 0.001, respectively, in comparison
with the control. Note that the expression of
Slp mutants lacking the C2B domain (i.e.,
C2B) had effects similar to those of the wild-
type Slps with regard to the number of
plasma membrane–docked vesicles (D) and
the percent R/D values (E), whereas expres-
sion of Slp mutants lacking the C2AB do-
mains (i.e., C2AB) significantly decreased
the number of plasma membrane–docked
vesicles (D) without altering the percent R/D
values (E).
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core vesicles to the plasma membrane, we prepared six
different chimeric constructs between Slp4-a and Slp5 and
assessed their plasma membrane–docking activity by TIRF
microscopy (summarized in Figure 5A). The results clearly
showed that the linker domain of Slp4-a is responsible for
vesicle docking to the plasma membrane (Figure 5, B and D).
Replacement of the linker domain of Slp4-a by the Slp5
linker (i.e., Slp4-SHDSlp5-linkerSlp4-C2A; hereafter sim-
Figure 5. Effect of the Slp4/5 chimeras on the
number of vesicles docked to the plasma mem-
brane of PC12 cells. (A) Schematic representa-
tion of Slp4/5 chimeras. The effects of each
mutant on plasma membrane–docked vesicles
and exocytosis (, , , ) are indicated
after its name. (B) Typical TIRF images of
plasma membrane–docked vesicles observed
before high-KCl stimulation in control (con-
trol), mRFP-Slp444, mRFP-Slp445, mRFP-
Slp455, mRFP-Slp454, mRFP-Slp555, mRFP-
Slp554, mRFP-Slp544, and mRFP-Slp545 cells.
Scale bar, 5 m. (C) Expression of the Slp4/5
chimeras and actin in PC12 cells visualized
with anti-DsRed antibody and anti-actin anti-
body, respectively. The positions of the molec-
ular mass markers (103) are shown on the
left. (D) The density of docked vesicles was
determined by counting the vesicles in each
image (n  6 cells in each). (E) The effect of
expression of the Slp4/5 chimeras on the per-
cent R/D. Data are shown as mean values 
SE. *,*** p 	 0.05, and 0.001, respectively, in
comparison with the control. Note that the ex-
pression of Slp4-a-linker-domain–containing
chimeras (i.e., Slp444, Slp445, Slp544, and
Slp545; gray bars) significantly increased the
number of plasma membrane-docked vesicles
(D) but decreased the percent R/D values (E).
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ply referred to as Slp454) completely abrogated the vesicle-
docking activity. Similarly, both the Slp455 and Slp554 chi-
meras, which contain the linker domain of Slp5, failed to
promote vesicle docking to the plasma membrane (hatched
bars in Figure 5D). By contrast, the Slp445, Slp544, and
Slp545 chimeras, which contain the linker domain of Slp4-a
showed a significant increase in the number of plasma mem-
brane–docked vesicles (gray bars in Figure 5D), although
the vesicle-docking activity of these chimeras were weaker
than that of Slp4-b (i.e., Slp444). Moreover, expression of the
Slp4-a linker–containing chimeras (i.e., Slp445, Slp544, and
Slp545 chimeras) significantly reduced the percent R/D val-
ues (normalized NPY-Venus release events), whereas other
chimeras that contain the Slp5-linker domain had no signif-
icant effect (Figure 5E). These results cannot be explained by
the different expression levels of chimeric constructs, be-
cause the expression levels of Slp4-b (i.e., Slp444), Slp5-C2B
(i.e., Slp555), and other chimeric constructs in PC12 cells
were almost the same (Figure 5C). We therefore concluded
that the linker domain of Slp4-a is responsible for the vesi-
cle-docking to the plasma membrane as well as for the
reduction of the percent R/D value, although the linker
domain alone is not sufficient for such activities and adjacent
SHD and C2A domains are also required.
The results of the chimeric analysis between Slp4 and Slp5
also provided important information about the promotion of
NPY-Venus release by Slp5. Because the Slp455 and Slp554
chimeras did not significantly increase the percent R/D values,
the Slp4-a SHD and the Slp4-a C2A domain cannot substitute
for the function of the Slp5 SHD and the Slp5 C2A domain,
respectively. Actually, the SHDs of Slp4-a and Slp5 have been
shown to differ, because only the former SHD interacts with
Rab27A(T23N), which mimics the GDP-bound form of Rab27A
(Fukuda, 2003), and the C2A domains of Slp4-a and Slp5 have
been shown to be different, because only the latter C2A domain
exhibits Ca2-dependent phospholipid-binding activity (Wang
et al., 1999; Fukuda, 2002; Kuroda et al., 2002b). These results
suggest that both the GTP-dependent Rab27A-binding ability
and the Ca2-dependent phospholipid-binding ability of Slp5
are necessary for it to exert its function during dense-core
vesicle exocytosis.
Silencing of Slp4-a with siRNA Reduces the Number of
Vesicles Docked to the Plasma Membrane and Increases
the Number of Exocytotic Events
Because we showed that Slp4-a, but not other Slps, is endog-
enously expressed in PC12 cells (Fukuda et al., 2002, and see
Supplementary Figure 1), we explored the role of endogenous
Slp4-a in dense-core vesicle exocytosis by RNA interference
technology combined with TIRF microscopy. Expression of the
Slp4-a siRNA reduced endogenous expression of Slp4-a (Fig-
ure 6A, top, lane 2) in PC12 cells, whereas a control pSilencer
vector had no effect at all (Figure 6A, top, lane 1). In addition,
expression of the Slp4-a siRNA had no effect on endogenous
expression of other exocytotic proteins, including Munc18-1,
syntaxin-1a, SNAP-25, VAMP-2, and Rab27A (Figure 6A). We
therefore concluded that the Slp4-a siRNA specifically down-
regulates endogenous Slp4-a in PC12 cells. Interestingly, ex-
pression of the Slp4-a siRNA (Figure 6, B and C) significantly
reduced the number of plasma membrane–docked vesicles (to
60.1%), compared with the control cells (Figure 6, C and D),
and, to our surprise, the percent of R/D value was increased to
180.4% in the Slp4-a-siRNA–expressing cells, compared with
the control cells (Figure 6D).
The Linker Domain of Slp4-a Interacts with Munc18-1
in PC12 Cells
In the final set of experiments, we attempted to determine
how the Slp4-a linker domain controls dense-core vesicle
exocytosis at the molecular level. Because it has recently
been shown that Slp4-a interacts with t-SNARE syntaxin-1a
and/or Munc18-1 (Coppola et al., 2002; Torii et al., 2002,
2004; Fukuda, 2003; Fukuda et al., 2005), we first investigated
the interaction between Slp4/Slp5 chimeras and Munc18-1
and syntaxin-1a by coimmunoprecipitation assay in COS-7
cells, which do not endogenously express neuronal SNARE-
related proteins (Fukuda et al., 2005). In brief, agarose beads
coupled with each T7-tagged Slp4/Slp5 chimera were incu-
bated with FLAG-Munc18-1, FLAG-syntaxin-1a, and HA-
Rab27A, and proteins trapped with the beads were analyzed
by immunoblotting (Figure 7). It was very interesting to find
that only the Slp4-linker-domain–containing chimeras (i.e.,
Slp445, Slp544, and Slp545) interacted with both Munc18-1
and syntaxin-1a (lanes 1, 2, 7, and 8 in Figure 7, A and B),
although all chimeras interacted normally with Rab27A
(Figure 7C). The interaction between Slp4 and syntaxin-1a
must be indirect, because syntaxin-1a failed to interact with
Sp4-a in the absence of Munc18-1 (Fukuda, 2003; but see
Figure 6. Effect of Slp4-a siRNA expression on the number of vesicles
docked to the plasma membrane of PC12 cells. (A) Effect of Slp4-a
siRNA on expression of Slp4-a in PC12 cells. PC12 cells were trans-
fected with pSilencer-Slp4-a (lane 2) or a control vector (lane 1). Cell
lysates were prepared and subjected to 12.5% SDS-PAGE followed by
immunoblotting with anti-Slp4-a (Imai et al., 2004), anti-actin (1/300
dilution), anti-Munc18-1 (1/100 dilution), anti-syntaxin-1a (1/100
dilution), anti-SNAP-25 (1/1000 dilution), anti-VAMP-2 (1/100 di-
lution), and anti-Rab27A antibody (3 g/ml). The positions of the
molecular mass markers (103) are shown on the left. (B) Typical
TIRF images of plasma membrane–docked vesicles before high-KCl
stimulation of control (left), Slp4-a–expressing (middle), and Slp4-
a-siRNA–expressing cells (right). Scale bar, 5 m. (C) The density of
docked vesicles was determined by counting the vesicles in each
image (n  7 cells in each). (D) The effect of the Slp4-a siRNA on the
percent R/D values (n  7 cells in each). The data are mean
values  SE. * p 	 0.05 in comparison with the control. Note that
expression of the Slp4-a siRNA significantly reduced the number of
plasma membrane–docked vesicles (C) and increased the percent
R/D values (D).
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Torii et al., 2002, who showed that syntaxin-1a interacts with
the N-terminal SHD in a Rab27A-dependent manner).
To confirm the above findings in PC12 cells, we further
tested the interaction between the linker-domain–swapping
mutants (i.e., Slp454 and Slp545) and endogenous Munc18-1,
syntaxin-1a, or Rab27A by coimmunoprecipitation assay in
PC12 cells. As anticipated, the Slp545 mutant interacted with
endogenous Munc18-1, syntaxin-1a, and Rab27A, the same as
Slp4-b did (lanes 5 and 8 in Figure 8), whereas Slp5-C2B and
Slp454 interacted with Rab27A alone, and not with Munc18-1
or syntaxin-1a (lanes 6 and 7).
Finally, we investigated the intracellular distribution of
Slp4-a, Munc18-1, and syntaxin-1a in PC12 cells by immuno-
fluorescence analysis. Comparison of the intracellular localiza-
tion of NPY-Venus, mRFP-Slp4-a, and Munc18-1 in PC12 cells
revealed that NPY-Venus labeled dense-core vesicles colocal-
ized well with both mRFP-Slp4-a and Munc18-1 (Figure 9,
A–D). Comparison of the intracellular localization of NPY-
Venus, mRFP-Slp4-a, and syntaxin-1a (Figure 9, E–H) showed
that colocalization between mRFP-Slp4-a (or NPY-Venus) and
syntaxin-1a was very limited (i.e., colocalization was only ob-
served immediately just beneath the plasma membrane; Figure
9H). These results, together with the results of the coimmuno-
precipitation assay above, strongly suggest that Slp4-a interacts
with Rab27A and Munc18-1 on dense-core vesicles and that the
interaction between the Rab27ASlp4-aMunc18-1 complex and
syntaxin-1a promotes anchoring of dense-core vesicles to the
plasma membrane.
DISCUSSION
In the present study we demonstrated that five Slp isoforms
tagged with mRFP are mainly targeted to dense-core vesicles in
PC12 cells (Figure 1) and affect dense-core vesicle exocytosis
differently (Figure 2). Expression of Slp4-a greatly increased the
number of plasma membrane-docked inert vesicles and inhib-
ited high-KCl–induced NPY-Venus release, whereas expres-
sion of either Slp3-a or Slp5, a Ca2-dependent-type Slp
(Fukuda et al., 2002; Fukuda, 2003), significantly enhanced
high-KCl–induced NPY-Venus release without changing the
number of vesicles docked to the plasma membrane. In addi-
tion, Slp4-a siRNA–expressing PC12 cells exhibited the dock-
ing defect, and high-KCl–induced NPY-Venus release events
were significantly increased in them (Figure 6). The inhibitory
effect of Slp4-a on dense-core vesicle exocytosis is perfectly
correlated with its ability to interact with the Munc18-1syn-
taxin-1a complex via the Slp4-a linker domain in PC12 cells, as
revealed by TIRF microscopy combined with deletion and
chimeric analyses (Figures 4, 5, 7, and 8). Because Slp4-a and
Munc18-1 colocalized well on NPY-Venus–containing vesicles
and the colocalization between Slp4-a and syntaxin-1a
was limited to immediately adjacent to the plasma mem-
brane (Figure 9), we propose the following model (Figure
10A, right panel): 1) Slp4-a is targeted to Rab27A on
dense-core vesicles via the SHD; 2) Munc18-1 is then
recruited and directly binds the linker domain of Slp4-a;
and 3) Munc18-1 in the Slp4-aMunc18-1 complex directly
binds the closed conformation of syntaxin-1a in the
plasma membrane. The resulting Rab27ASlp4-aMunc18-
1syntaxin-1a quadripartite complex links dense-core ves-
icles to the plasma membrane. Similar docking machinery
consisting of Rab27ASlp2-aphosphatidylserine or Rab27A
rabphilinSNAP-25 has recently been reported in melanosome
anchoring to the plasma membrane in melanocytes (Kuroda
and Fukuda, 2004) and docking of dense-core vesicles to the
plasma membrane in PC12 cells (Tsuboi and Fukuda, 2005;
Fukuda, 2006), respectively. Although this manuscript was
being prepared, Slp4-a–deficient mice whose pancreatic -cells
contain decreased numbers of docked vesicles and exhibit in-
Figure 7. Munc18-1 and syntaxin-1a interact with Slp4-a in a
Slp4-linker-domain–dependent manner. Beads coupled with each
T7-Slp4/5 chimera were incubated with FLAG-Munc18-1, FLAG-
syntaxin-1a, and HA-Rab27A, and coimmunoprecipitated FLAG-
tagged proteins and HA-Rab27A were detected with HRP-conju-
gated anti-FLAG tag antibody (Blot: anti-FLAG, in A and B) and
HRP-conjugated anti-HA tag antibody (Blot: anti-HA, in C), respec-
tively. The same blots were then stripped and reprobed with HRP-
conjugated anti-T7 tag antibody to ensure that equivalent amounts
of T7-tagged proteins had been loaded (Blot: anti-T7, bottom panel
in A). Input means one tenth the volume of the reaction mixture
used for immunoprecipitation (IP). The positions of the molecular
mass markers (103) are shown on the left. Note that Slp4-linker-
domain-containing chimeras (i.e., Slp445, Slp544, or Slp545) inter-
acted with both Munc18-1 and syntaxin-1a (lanes 1, 2, 7, and 8 in the
middle panel of A and the bottom panel in B).
Figure 8. In vivo interaction between Slp4/5 chimeras and
SNARE-related proteins in PC12 cells. Slp4-linker-domain–contain-
ing molecules (i.e., Slp4-b and Slp545; see lanes 5 and 8), but not
Slp5-linker-domain–containing molecules (i.e., Slp454 and Slp5-
C2B; see lanes 6 and 7), efficiently immunoprecipitated Munc18-1
and syntaxin-1a. Immunoprecipitation (IP) and immunoblotting
were performed as described in Materials and Methods. Input means
one tenth the volume of the reaction mixtures used for immunopre-
cipitation (lanes 1–4).
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creased insulin secretion activity have been reported (Gomi et
al., 2005), quite consistent with our own results. Although
Gomi et al. (2005) claimed that direct interaction between Slp4-a
and syntaxin-1a mediates vesicle docking to the plasma mem-
brane (Figure 10A, left panel), our findings in this study
strongly conflict with that notion and indicate that the interac-
tion between the Slp4-a linker domain and the Munc18-1syt-
naxin-1a complex mediates vesicle docking to the plasma
membrane. Consistent with this, the level of expression of both
Munc18-1 and syntaxin-1a was reduced in the Slp4-a–deficient
mice (Gomi et al., 2005).
Although Munc18-1–deficient mice are known to have
normal synaptic structures (i.e., docking of synaptic vesicles
to the presynaptic plasma membrane is normal; Verhage et
al., 2000), a defect in the dense-core vesicle docking to the
plasma membrane in neuroendocrine cells has recently been
reported (Voets et al., 2001; Korteweg et al., 2005). Moreover,
Munc18-1 has been proposed to regulate more than one
stage (e.g., docking and fusion) of dense-core vesicle exocy-
tosis (Fisher et al., 2001; Graham et al., 2004; Ciufo et al.,
2005), possibly by binding different binding partners (e.g.,
syntaxin-1a and Doc2; Verhage et al., 1997). How Munc18-1
controls the docking step of dense-core vesicle exocytosis,
however, had never been elucidated. In the present study
we demonstrated for the first time that Slp4-a is an in vivo
Munc18-1–binding partner that contributes to the docking
of dense-core vesicles to the plasma membrane of PC12 cells.
This docking machinery seems to be specific to dense-core
vesicles in certain neuroendocrine cells, because Slp4-a is not
expressed in neurons (or on synaptic vesicles) and is un-
likely to be involved in the synaptic vesicle-docking step.
Why do Slp4-a–deficient PC12 cells exhibit increased dense-
core vesicle exocytosis? We think that the enhancement of
dense-core vesicle exocytosis by Slp4-a knockdown might be
explained by the presence of a variety of Rab3A and Rab27A
effectors in neuroendocrine cells (Cheviet et al., 2004; Fukuda,
Figure 9. Colocalization of Slp4-a, Munc18-1,
syntaxin-1a, and secretory peptide in PC12
cells. NPY-Venus (A and E) and mRFP-Slp4-a
(B and F) were coexpressed in PC12 cells. Two
days after transfection, the cells were fixed and
stained with anti-Munc18-1 (C) or anti-syn-
taxin-1a antibody (G). The images of the cells
were obtained by confocal microscopy. Scale
bars, 10 m. Note that Munc18-1 colocalized
well with both the dense-core vesicle marker
NPY-Venus and mRFP-Slp4-a (D), whereas
syntaxin-1a partially colocalized with mRFP-
Slp4-a (H) immediately adjacent to the plasma
membrane.
Figure 10. Proposed model for Slp/rabphilin-depen-
dent dense-core vesicle exocytosis in neuroendocrine cells.
(A) Vesicle docking machinery proposed by Gomi et al.
(2005) (left panel) and by the authors based on the results
of the present study (right panel). (B) Slp15 and rabphi-
lin are recruited to dense-core vesicles through specific
interaction with Rab27A/B on dense-core vesicles
(Fukuda et al., 2004 and this study). Rabphilin and Slp4-a
promote docking of dense-core vesicles to the plasma
membrane through interaction with SNAP-25 (Tsuboi and
Fukuda, 2005; Fukuda, 2006) and Munc18-1syntaxin-1a
complex (shown in A, right panel), respectively. Dense-
core vesicles docked to the plasma membrane by the
former complex (i.e., Rab27rabphilinSNAP-25) undergo
exocytosis in response to high-KCl stimulation (presum-
ably corresponds to the “readily releasable pool”),
whereas dense-core vesicles docked to the plasma mem-
brane by the latter complex (i.e., Rab27Slp4-aMunc18-
1sytnaxin-1a) are insensitive to high-KCl stimulation. The
physiological significance of the high-KCl-stimulation–in-
sensitive population of vesicles (i.e., “inert vesicles”) is
currently unknown. Slp3-a and Slp5, Ca2-dependent-
type Slps, promote sustained exocytosis of dense-core ves-
icles that are not predocked to the plasma membrane
(presumably corresponds to the “releasable pool”) by
largely unknown mechanisms. In the absence of Slp4-a,
other Ca2-dependent Slps or rabphilin presumably oc-
cupy Rab27 on the vesicles, and thereby promote sus-
tained exocytotic events.
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2005), and several Rab27A effectors (e.g., rabphilin, Slp4-a,
Slp5, Noc2, and Slac2-c) are in fact expressed in PC12 cells or
pancreatic -cell lines (Fukuda et al., 2002, 2004; Desnos et al.,
2003; Waselle et al., 2003). For example, rabphilin has recently
been shown to promote the docking of dense-core vesicles to
the plasma membrane through simultaneous interaction with
Rab27A on the dense-core vesicle and SNAP-25 at the plasma
membrane via the C2B domain and enhance individual exocy-
totic events (Tsuboi and Fukuda, 2005). Thus, it is highly pos-
sible that other Rab27A effectors occupy Rab27A on dense-core
vesicles, instead of Slp4-a, in Slp4-a–deficient cells and enhance
dense-core vesicle exocytosis by promoting the recruitment,
docking, and/or priming of dense-core vesicles (Figure 10B).
Regulated exocytosis is generally thought to occur at two
different pools, a “readily releasable pool” and “releasable
pool.” In PC12 cells, the former pool corresponds to the initial
high-KCl–induced NPY-Venus release by vesicles predocked
to the plasma membrane, and the latter mainly corresponds to
the sustained NPY-Venus release by newly recruited undocked
vesicles. It is interesting that expression of Slp3-a or Slp5 in
PC12 cells significantly increased the sustained NPY-Venus
release (Figure 3C), suggesting that predocking of dense-core
vesicles to the plasma membrane may not be required for
dense-core vesicle exocytosis from the releasable pool. In ad-
dition, recent studies have demonstrated that mobile undocked
vesicles support exocytosis more efficiently than immobile
docked vesicles in the growth cones of PC12 cells, pancreatic
-cells, and hippocampal neurons (Han et al., 1999; Tsuboi and
Rutter, 2003; Tsuboi et al., 2003; Silverman et al., 2005). We
therefore speculate that Slp3-a and Slp5 regulate the number of
“release-competent” secretory vesicles or function as a priming
factor together with an unidentified binding protein(s). Further
study is needed to identify the binding proteins of Slp3-a and
Slp5 and how Slp3-a and Slp5 facilitate dense-core vesicle
exocytosis by PC12 cells or other types of secretory vesicle
exocytosis (e.g., exocrine exocytosis and secretion by immune
cells) at the molecular level.
In summary, we have demonstrated by in vivo binding
assays and live cell TIRF imaging that Slp4-a interacts with
syntaxin-1a in a Munc18-1–dependent manner via the linker
domain of Slp4-a, and we propose that the Rab27ASlp4-
aMunc18-1syntaxin-1a complex mediates dense-core vesicle
docking to the plasma membrane in PC12 cells.
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Südhof, T. C. (1997). DOC2 proteins in rat brain: complementary distribution
and proposed function as vesicular adapter proteins in early stages of secre-
tion. Neuron 18, 453–461.
Verhage, M. et al. (2000). Synaptic assembly of the brain in the absence of
neurotransmitter secretion. Science 287, 864–869.
Voets, T., Toonen, R. F., Brian, E. C., de Wit, H., Moser, T., Rettig, J., Südhof,
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